Company Filing History:
1 out of 5 
1 out of 48 
Years Active: 2016
Title: Inventor Maarten T Penning: Pioneering Mitochondrial Diagnostics
Introduction
Maarten T Penning, an innovative inventor based in Utrecht, Netherlands, has made significant contributions to the field of diagnostics through his groundbreaking work. With one patent to his name, he demonstrates a commitment to enhancing our understanding of health status using cutting-edge technology.
Latest Patents
Maarten T Penning is credited with a patent entitled "Mitochondrion-bound nucleic acid for determining a health status of an individual." This invention outlines novel means and methods for identifying mitochondrion-bound nucleic acid, emphasizing its application in diagnostics. The focus on preferable cell-free mitochondrion-bound nucleic acid marks an important advancement in health assessment methodologies.
Career Highlights
Throughout his career, Penning has been associated with notable companies such as Primagen Holding B.V. and UMC Utrecht Holding B.V. His work at these institutions has provided him with a solid foundation to pursue innovations that bridge the gap between research and practical applications in health diagnostics.
Collaborations
Maarten T Penning has collaborated with esteemed colleagues in his field, including Henriette C G I M Maas and Marinus Petrus De Baar. These partnerships reflect a shared vision for advancing scientific knowledge and improving diagnostic practices, highlighting the collaborative nature of innovation in the medical field.
Conclusion
In summary, Maarten T Penning's inventive contributions, particularly his patent related to mitochondrion-bound nucleic acids, position him as a significant figure in the realm of diagnostics. His collaborative work with other professionals and his experience in reputable companies underscore the importance of innovation in improving health outcomes.